The global drug-device combination products market is projected to experience a compound annual growth rate (CAGR) of approximately 9% during the forecast period. This growth is largely driven by the ...
The device-drug relationships can be very profitable to device companies; drug-eluting stent sales have rung up billions of dollars in sales annually. Yet, for these relationships to succeed, device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback